Membrane Attack by Complement: the Assembly and Biology of Terminal Complement Complexes

Overview

Journal Immunol Res

Specialty Allergy & Immunology

Date 2011 Aug 19

PMID 21850539

Citations 134

Authors

Cosmin A Tegla

Cornelia Cudrici

Snehal Patel

Richard Trippe 3rd

Violeta Rus

Florin Niculescu

Horea Rus

Affiliations

Soon will be listed here.

Abstract

Complement system activation plays an important role in both innate and acquired immunity. Activation of the complement and the subsequent formation of C5b-9 channels (the membrane attack complex) on the cell membranes lead to cell death. However, when the number of channels assembled on the surface of nucleated cells is limited, sublytic C5b-9 can induce cell cycle progression by activating signal transduction pathways and transcription factors and inhibiting apoptosis. This induction by C5b-9 is dependent upon the activation of the phosphatidylinositol 3-kinase/Akt/FOXO1 and ERK1 pathways in a Gi protein-dependent manner. C5b-9 induces sequential activation of CDK4 and CDK2, enabling the G1/S-phase transition and cellular proliferation. In addition, it induces RGC-32, a novel gene that plays a role in cell cycle activation by interacting with Akt and the cyclin B1-CDC2 complex. C5b-9 also inhibits apoptosis by inducing the phosphorylation of Bad and blocking the activation of FLIP, caspase-8, and Bid cleavage. Thus, sublytic C5b-9 plays an important role in cell activation, proliferation, and differentiation, thereby contributing to the maintenance of cell and tissue homeostasis.

Citing Articles

The role of complement in tumor immune tolerance and drug resistance: a double-edged sword.

Yang R, Fu D, Liao A Front Immunol. 2025; 16:1529184.

PMID: 39958348 PMC: 11825488. DOI: 10.3389/fimmu.2025.1529184.

Functional mass spectrometry indicates anti-protease and complement activity increase with COVID-19 severity.

Fraser D, Roy S, Kuruc M, Quintero M, Van Nynatten L, Cepinskas G Exp Biol Med (Maywood). 2025; 250:10308.

PMID: 39949890 PMC: 11813650. DOI: 10.3389/ebm.2025.10308.

Large and Stable Nanopores Formed by Complement Component 9 for Characterizing Single Folded Proteins.

Chanakul W, Mukhopadhyay A, Awasthi S, Protopopova A, Ianiro A, Mayer M ACS Nano. 2025; 19(5):5240-5252.

PMID: 39871506 PMC: 11823641. DOI: 10.1021/acsnano.4c11666.

Microglia-mediated neuroinflammation in traumatic brain injury: a review.

Obukohwo O, Oreoluwa O, Andrew U, Williams U Mol Biol Rep. 2024; 51(1):1073.

PMID: 39425760 DOI: 10.1007/s11033-024-09995-4.

Analysis of Intervertebral Disc Degeneration Induced by Endplate Drilling or Needle Puncture in Complement C6-Sufficient and C6-Deficient Rabbits.

Kuhn A, Huber-Lang M, Weckbach S, Riegger J, Teixeira G, Rasche V Biomedicines. 2024; 12(8).

PMID: 39200157 PMC: 11351780. DOI: 10.3390/biomedicines12081692.

References

Podack E, Tschopp J . Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc Natl Acad Sci U S A. 1982; 79(2):574-8. PMC: 345787. DOI: 10.1073/pnas.79.2.574. View

Papadimitriou J, Ramm L, Drachenberg C, Trump B, Shin M . Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9. J Immunol. 1991; 147(1):212-7. View

Kissel J, Mendell J, Rammohan K . Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med. 1986; 314(6):329-34. DOI: 10.1056/NEJM198602063140601. View

Kilgore K, Schmid E, Shanley T, FLORY C, Maheswari V, Tramontini N . Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol. 1997; 150(6):2019-31. PMC: 1858311. View

Oksjoki R, Kovanen P, Mayranpaa M, Laine P, Blom A, Meri S . Complement regulation in human atherosclerotic coronary lesions. Immunohistochemical evidence that C4b-binding protein negatively regulates the classical complement pathway, and that C5b-9 is formed via the alternative complement pathway. Atherosclerosis. 2006; 192(1):40-8. DOI: 10.1016/j.atherosclerosis.2006.06.013. View

Charbel Issa P, Chong N, Scholl H . The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol. 2010; 249(2):163-74. PMC: 3042099. DOI: 10.1007/s00417-010-1568-6. View

Badea T, Niculescu F, Soane L, Fosbrink M, Sorana H, Rus V . RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase. J Biol Chem. 2001; 277(1):502-8. DOI: 10.1074/jbc.M109354200. View

Deguchi M, Gillin F, Gigli I . Mechanism of killing of Giardia lamblia trophozoites by complement. J Clin Invest. 1987; 79(5):1296-302. PMC: 424366. DOI: 10.1172/JCI112952. View

Marraccino R, Firpo E, Roberts J . Activation of the p34 CDC2 protein kinase at the start of S phase in the human cell cycle. Mol Biol Cell. 1992; 3(4):389-401. PMC: 275590. DOI: 10.1091/mbc.3.4.389. View

10.

Kuehn M, Kim C, Ostojic J, Bellin M, Alward W, Stone E . Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp Eye Res. 2006; 83(3):620-8. DOI: 10.1016/j.exer.2006.03.002. View

11.

Rus H, Niculescu F, Badea T, Shin M . Terminal complement complexes induce cell cycle entry in oligodendrocytes through mitogen activated protein kinase pathway. Immunopharmacology. 1998; 38(1-2):177-87. DOI: 10.1016/s0162-3109(97)00063-5. View

12.

Furukawa Y, Piwnica-Worms H, Ernst T, Kanakura Y, Griffin J . cdc2 gene expression at the G1 to S transition in human T lymphocytes. Science. 1990; 250(4982):805-8. DOI: 10.1126/science.2237430. View

13.

ter Weeme M, Vonk A, Kupreishvili K, van Ham M, Zeerleder S, Wouters D . Activated complement is more extensively present in diseased aortic valves than naturally occurring complement inhibitors: a sign of ongoing inflammation. Eur J Clin Invest. 2009; 40(1):4-10. DOI: 10.1111/j.1365-2362.2009.02216.x. View

14.

Soane L, Rus H, Niculescu F, Shin M . Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation. J Immunol. 1999; 163(11):6132-8. View

15.

Bjerre M, Holland-Fischer P, Gronbaek H, Frystyk J, Hansen T, Vilstrup H . Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections. World J Hepatol. 2010; 2(6):221-5. PMC: 2999289. DOI: 10.4254/wjh.v2.i6.221. View

16.

Kumar R, Cann C, Hall J, Sudheer P, Wilkes A . Predictive value of IL-18 and SC5b-9 for neurocognitive dysfunction after cardiopulmonary bypass. Br J Anaesth. 2007; 98(3):317-22. DOI: 10.1093/bja/ael366. View

17.

Dalmasso A, Benson B . Lesions of different functional size produced by human and guinea pig complement in sheep red cell membranes. J Immunol. 1981; 127(6):2214-8. View

18.

Niculescu F, Rus H, Porutiu D, Ghiurca V, Vlaicu R . Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall. Atherosclerosis. 1989; 78(2-3):197-203. DOI: 10.1016/0021-9150(89)90223-2. View

19.

Young J, COHN Z, Podack E . The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities. Science. 1986; 233(4760):184-90. DOI: 10.1126/science.2425429. View

20.

Gerl V, Bohl J, Pitz S, Stoffelns B, Pfeiffer N, Bhakdi S . Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2002; 43(4):1104-8. View